Related Experiment Videos
Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung
M T Stahlman1, M E Gray, J A Whitsett
1Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Insights
Thyroid transcription factor-1 (TTF-1) is present in fetal lung cells by 11 weeks and primarily in Type II epithelial cells at term. Its distribution changes in hyaline membrane disease and bronchopulmonary dysplasia, reflecting lung development and injury.
Area of Science:
- Pulmonary Medicine
- Developmental Biology
- Cellular Biology
Background:
- Thyroid transcription factor-1 (TTF-1) is a key regulator of lung development.
- Understanding TTF-1's expression is crucial for diagnosing and managing neonatal lung diseases.
Purpose of the Study:
- To investigate the temporal and spatial expression of TTF-1 in developing and diseased human lungs.
- To correlate TTF-1 distribution with lung maturation and pathological conditions like Hyaline Membrane Disease (HMD) and Bronchopulmonary Dysplasia (BPD).
Main Methods:
- Immunohistochemical analysis of lung tissue from human fetuses, healthy infants, and infants with HMD or BPD.
- Assessed TTF-1 localization in epithelial cell nuclei across different gestational ages and disease states.
Main Results:
- TTF-1 was detected in fetal lung epithelial cells by 11 weeks gestation, with prominent staining in airway budding tips.
- At term, TTF-1 was mainly in Type II epithelial cells; its expression was reduced in HMD and altered in BPD lungs, particularly in collapsed or infected areas.
- TTF-1 distribution generally mirrored that of surfactant protein-B, suggesting a role in epithelial gene regulation.
Conclusions:
- TTF-1 expression follows a specific developmental trajectory in the human lung.
- Altered TTF-1 localization in HMD and BPD indicates its sensitivity to lung injury and repair processes.
- TTF-1 serves as a marker for lung epithelial cell differentiation and function during development and disease.
Abstract:
We assessed the immunohistochemical localization of thyroid transcription factor-1 (TTF-1) in the lungs of 24 human fetuses (11-23 weeks), three infants without pulmonary pathology (36-42 weeks), and 24 infants (2 days-6.5 months) with hyaline membrane disease (HMD) or bronchopulmonary dysplasia (BPD). TTF-1 was detected in fetal lung epithelial cell nuclei by 11 weeks' gestation. Budding tips of terminal airways had prominently labeled nuclei. By 17 weeks, labeling was present in scattered nonciliated columnar and cuboidal cells. Throughout gestation, TTF-1 nuclear staining was prominent in airways abutting pleural, peribronchial, or perivascular connective tissue, being less prominent in centers of lobules. By 23 weeks, many cells in cuboidal but not columnar cell-lined airways had labeled nuclei. At term, TTF-1 was detected primarily in Type II epithelial cells. In HMD with alveolar hemorrhage, edema, or airway collapse, little or no TTF-1 was present except in open terminal airways. In BDP lungs, TTF-1 was absent in areas of alveolar collapse or infection, being present in regenerating open airways. The temporal-spatial distribution of TTF-1, in general, follows patterns of distribution of surfactant protein-B in developing and pathological lungs, consistent with its role in the regulation of epithelial cell gene expression in the lung.